SOM Biotech will attend the First European Congress on Hereditary ATTR Amyloidosis to be held in Paris, from November 2nd – 3rd 2015. SOM Biotech team will present the preliminary results of Phase 2a clinical trial with SOM0226 on ATTR Amyloidosis, which has recently been successfully completed.

For further information please visit  http://www.ec-attr.com